Trial Details

COMPLETED
Basic Information
Clinical ID c4747
Identifier NCT00032786
Trial Title Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: natalizumab
Participant Information
Sponsor Biogen
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2002-03
Primary Completion Date 2004-03
Completion Date 2004-03